<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="7353" whole_study_id="7353" phs="000519" v="1" p="1" createDate="2011-09-14T13:23:59-05:00" completedByGPADate="2014-02-27T11:44:30-05:00" modDate="2019-05-07T16:41:56-05:00" maxParentChildStudyModDate="2019-05-07T16:41:56-05:00" handle="CIDR_Melanoma_AustraliaUK" num_participants="3963"><StudyInfo accession="phs000519.v1.p1" parentAccession="phs000519.v1.p1"><BioProject id="PRJNA171343" entrez_id="171343" type="bp_admin_access"/><BioProject id="PRJNA171344" entrez_id="171344" type="bp_data_submission"/><StudyNameEntrez>CIDR_Melanoma GWAS</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType></StudyTypes><Funding>R01 CA088363-10</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false"/></ICs><Persons><Person nedid="N_HAYWARD" aid="2" auth="eRA" login="N_HAYWARD" fname="Nicholas" mname="K" lname="Hayward" email="Nick.Hayward@qimr.edu.au"><Role>PI</Role><Organization>QUEENSLAND INSTITUTE OF MEDICAL RESEARCH</Organization></Person><Person nedid="0010196336" aid="1" auth="cit" login="seminard" fname="Daniela" mname="" lname="Seminara" email="seminard@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>The Leeds component of the study was funded by the European Commission under the 6th Framework Programme, contract no: LSHC-CT-2006-018702; by Cancer Research UK Programme Awards, C588/A4994 and C588/A10589, and Cancer Research UK Project Grant C8216/A6129; and by US National Institutes of Health R01 ROI CA83115. The Cambridge melanoma studies were supported by Cancer Research UK grants C490/A10124 (SEARCH) and C1287/A10118 (MAPLES). The WAMHS data collection was supported by funding from the Scott Kirkbride Melanoma Research Centre and The University of Western Australia. The Western Australian DNA Bank is gratefully acknowledged for assistance and support with biospecimens, and the Ark for informatics support. The Western Australian Cancer Registry is also acknowledged for their assistance.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="888" CGType="cg_class_DS" title="Disease-Specific (Melanoma, MDS)" name="DS-M-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Melanoma.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="959" CGType="cg_class_GRU" title="General Research Use (MDS)" name="GRU-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>